Show simple item record

dc.contributor.authorAngelini, Michael
dc.date2022-08-11T08:08:06.000
dc.date.accessioned2022-08-23T15:42:35Z
dc.date.available2022-08-23T15:42:35Z
dc.date.issued2015-02-28
dc.date.submitted2017-12-14
dc.identifier.doi10.13028/dnsm-7f04
dc.identifier.urihttp://hdl.handle.net/20.500.14038/26884
dc.description.abstractThis presentation describes the possible benefits and risks associated with the concomitant use of opiate and benzodiazepine medications. Presented at the American Drug Utilization Review Society 2015 Conference.
dc.language.isoen_US
dc.subjectopiates
dc.subjectbenzodiazepines
dc.subjectbehavioral health
dc.subjectopioid management
dc.subjectpharmacy
dc.subjectdrug utilization review
dc.subjectHealth Economics
dc.subjectHealth Law and Policy
dc.subjectHealth Policy
dc.subjectHealth Services Administration
dc.subjectHealth Services Research
dc.subjectPharmacy and Pharmaceutical Sciences
dc.titleRisk and Benefit of the Concomitant Use of Benzodiazepines and Opiates
dc.typePresentation
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1124&context=commed_pubs&unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/commed_pubs/120
dc.identifier.contextkey11253740
refterms.dateFOA2022-08-23T15:42:35Z
html.description.abstract<p>This presentation describes the possible benefits and risks associated with the concomitant use of opiate and benzodiazepine medications.</p> <p>Presented at the American Drug Utilization Review Society 2015 Conference.</p>
dc.identifier.submissionpathcommed_pubs/120
dc.contributor.departmentCommonwealth Medicine, Clinical Pharmacy Services


Files in this item

Thumbnail
Name:
9293__Risk_and_Benefit_of_the_ ...
Size:
275.9Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record